CRL Insights:
  Cell Therapy:
    General:
      US (FDA):
        Guidance Summary:
          - Public CRL themes include potency, APS, comparability, PPQ, CTD consistency.
        Suggested next steps:
          - Strengthen potency rationale; finalize APS; define decision rules; confirm PPQ; align CTD.
      EU (EMA):
        Guidance Summary:
          - EMA feedback similar; ensure validation narratives and CTD mapping fit MAA.
        Suggested next steps:
          - Plan Scientific Advice; finalize EU mapping and terminology.
